Stewart McCallum Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Stewart McCallum.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Stewart McCallum. Stewart McCallum is Chief Medical Officer in Recro Pharma, Inc. ($REPH).
Latest Insider Trading Transactions of Stewart McCallum
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 22 2018 | REPH | Recro Pharma, Inc. | McCallum Stewart | Chief Medical Offic ... | Option Exercise | M | 0.00 | 6,000 | 0 | 18,000 | |
| Jan 22 2018 | REPH | Recro Pharma, Inc. | McCallum Stewart | Chief Medical Offic ... | Payment of Exercise | F | 8.89 | 1,860 | 16,535 | 31,841 | 33.7 K to 31.8 K (-5.52 %) |
| Jan 22 2018 | REPH | Recro Pharma, Inc. | McCallum Stewart | Chief Medical Offic ... | Buy | M | 0.00 | 6,000 | 0 | 33,701 | 27.7 K to 33.7 K (+21.66 %) |
| Jan 04 2018 | REPH | Recro Pharma, Inc. | McCallum Stewart | Chief Medical Offic ... | Option Exercise | A | 9.04 | 32,200 | 291,088 | 32,200 | |
| Jan 04 2018 | REPH | Recro Pharma, Inc. | McCallum Stewart | Chief Medical Offic ... | Grant | A | 0.00 | 16,100 | 0 | 27,701 | 11.6 K to 27.7 K (+138.78 %) |
| Oct 02 2017 | REPH | Recro Pharma, Inc. | McCallum Stewart | Chief Medical Offic ... | Payment of Exercise | F | 9.04 | 4,649 | 42,027 | 11,601 | 16.3 K to 11.6 K (-28.61 %) |
| Oct 02 2017 | REPH | Recro Pharma, Inc. | McCallum Stewart | Chief Medical Offic ... | Buy | M | 0.00 | 15,000 | 0 | 16,250 | 1.3 K to 16.3 K (+1,200.00 %) |
| Jan 20 2017 | REPH | Recro Pharma, Inc. | McCallum Stewart | Chief Medical Offic ... | Option Exercise | A | 0.00 | 24,000 | 0 | 24,000 | |
| Jan 20 2017 | REPH | Recro Pharma, Inc. | McCallum Stewart | Chief Medical Offic ... | Option Exercise | A | 7.33 | 36,000 | 263,880 | 36,000 | |
| May 31 2016 | REPH | Recro Pharma, Inc. | McCallum Stewart | Chief Medical Offic ... | Buy | P | 8.50 | 250 | 2,125 | 1,250 | 1,000 to 1.3 K (+25.00 %) |
| May 31 2016 | REPH | Recro Pharma, Inc. | McCallum Stewart | Chief Medical Offic ... | Buy | P | 8.15 | 1,000 | 8,150 | 1,000 | 0 to 1,000 |
| Dec 02 2015 | REPH | Recro Pharma, Inc. | McCallum Stewart | Chief Medical Offic ... | Option Exercise | A | 9.29 | 103,000 | 956,870 | 103,000 |
Page: 1